Israeli ingredients group Gadot Biochemical Industries has acquired an 85% stake in Florida-based US ingredients company Pharmline Holding.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


Pharmline is a private company that processes and markets ingredients and premixes to the nutraceuticals market in North America. The group posted 2006 revenues of approximately US$37m


“The acquisition of Pharmline is in line with Gadot’s growth strategy — focusing on the nutraceutical and functional food markets,” Jacob Zack, CEO of Gadot, commented. “Pharmline is an important link in the supply chain to these markets and this acquisition will enable Gadot to diversify its products line and to broaden its customer base in North America.”


The deal is expected to be completed by the end of June.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact